Table 2:
Characteristic | Individuals without schizophrenia | Individuals with schizophrenia | ||||
---|---|---|---|---|---|---|
|
|
|||||
No. (%) of deaths | Population 15–105 yr, no. (%) | Crude rate per 1000 (95% CI) | No. (%) of deaths | Population 15–105 yr, no. (%) | Crude rate per 1000 (95% CI) | |
Overall | 86 751 (100) | 11 750 416 (100) | 7.38 (7.33–7.43) | 2074 (100) | 111 695 (100) | 18.57 (17.78–19.39) |
| ||||||
Age group, yr | ||||||
| ||||||
15–24 | 636 (0.7) | 1 808 089 (15.4) | 0.35 (0.32–0.38) | 17 (0.8) | 6215 (5.6) | 2.74 (1.59–4.38) |
| ||||||
25–34 | 796 (0.9) | 1 852 851 (15.8) | 0.43 (0.40–0.46) | 69 (3.3) | 17 051 (15.3) | 4.05 (3.15–5.12) |
| ||||||
35–44 | 1563 (1.8) | 1 970 832 (16.8) | 0.79 (0.75–0.83) | 104 (5.0) | 20 399 (18.3) | 5.10 (4.17–6.18) |
| ||||||
45–54 | 4619 (5.3) | 2 203 331 (18.8) | 2.10 (2.04–2.16) | 271 (13.1) | 27 255 (24.4) | 9.94 (8.79–11.2) |
| ||||||
55–64 | 9345 (10.8) | 1 752 481 (14.9) | 5.33 (5.22–5.44) | 398 (19.2) | 21 501 (19.2) | 18.51 (16.74–20.42) |
| ||||||
65–74 | 14 212 (16.4) | 1 138 500 (9.7) | 12.48 (12.28–12.69) | 433 (20.9) | 11 311 (10.1) | 38.28 (34.76–42.06) |
| ||||||
75–84 | 24 179 (27.9) | 681 293 (5.8) | 35.49 (35.04–35.94) | 433 (20.9) | 5490 (4.9) | 78.87 (71.62–86.66) |
| ||||||
≥ 85 | 31 401 (36.2) | 343 039 (2.9) | 91.54 (90.53–92.56) | 349 (16.8) | 2473 (2.2) | 141.12 (126.7–156.73) |
| ||||||
Sex | ||||||
| ||||||
Female | 43 100 (49.7) | 6 002 623 (51.1) | 7.18 (7.11–7.25) | 1090 (52.6) | 49 945 (44.7) | 21.82 (20.55–23.16) |
| ||||||
Male | 43 651 (50.3) | 5 747 793 (48.9) | 7.59 (7.52–7.67) | 984 (47.4) | 61 750 (55.3) | 15.94 (14.95–16.96) |
| ||||||
Neighbourhood income quintile | ||||||
| ||||||
Q1 (lowest) | 19 655 (22.7) | 2 245 174 (19.1) | 8.75 (8.63–8.88) | 706 (34.0) | 38 091 (34.1) | 18.53 (17.19–19.95) |
| ||||||
Q2 | 17 789 (20.5) | 2 308 559 (19.6) | 7.71 (7.59–7.82) | 392 (18.9) | 24 232 (21.7) | 16.18 (14.61–17.86) |
| ||||||
Q3 | 16 811 (19.4) | 2 330 823 (19.8) | 7.21 (7.10–7.32) | 365 (17.6) | 18 537 (16.6) | 19.69 (17.72–21.82) |
| ||||||
Q4 | 16 353 (18.9) | 2 445 142 (20.8) | 6.69 (6.59–6.79) | 309 (14.9) | 16 466 (14.7) | 18.77 (16.73–20.98) |
| ||||||
Q5 (highest) | 15 704 (18.1) | 2 371 682 (20.2) | 6.62 (6.52–6.73) | 277 (13.4) | 13 490 (12.1) | 20.53 (18.19–23.10) |
| ||||||
Unknown | 439 (0.5) | 49 036 (0.4) | 8.95 (8.13–9.83) | 25 (1.2) | 879 (0.8) | 28.44 (18.41–41.99) |
| ||||||
Dwelling | ||||||
| ||||||
Urban | 73 862 (85.1) | 10 422 041 (88.7) | 7.09 (7.04–7.14) | 1863 (89.8) | 102 191 (91.5) | 18.23 (17.41–19.08) |
| ||||||
Rural | 12 855 (14.8) | 1 323 106 (11.3) | 9.72 (9.55–9.89) | 208 (10.0) | 9439 (8.5) | 22.04 (19.14–25.24) |
| ||||||
Unknown | 34 (< 0.1) | 5269 (< 0.1) | 6.45 (4.47–9.02) | ≤ 5 | 65 (0.1) | 46.15 (9.52–134.88) |
| ||||||
Cause of death*† | ||||||
| ||||||
Circulatory | 23 958 (27.6) | 11 750 416 (100) | 2.04 (2.01–2.06) | 521 (25.1) | 111 695 (100) | 4.66 (4.27–5.08) |
| ||||||
Neoplasm | 27 254 (31.4) | 11 750 416 (100) | 2.32 (2.29–2.35) | 396 (19.1) | 111 695 (100) | 3.55 (3.20–3.91) |
| ||||||
Metabolic‡ | 7326 (8.4) | 11 750 416 (100) | 0.62 (0.61–0.64) | 194 (9.4) | 111 695 (100) | 1.74 (1.50–2.00) |
| ||||||
Respiratory | 7505 (8.7) | 11 750 416 (100) | 0.64 (0.62–0.65) | 207 (10.0) | 111 695 (100) | 1.85 (1.61–2.12) |
| ||||||
Accidental§ | 4217 (4.9) | 11 750 416 (100) | 0.36 (0.35–0.37) | 144 (6.9) | 111 695 (100) | 1.29 (1.09–1.52) |
| ||||||
Suicide | 1078 (1.2) | 11 750 416 (100) | 0.09 (0.09–0.10) | 98 (4.7) | 111 695 (100) | 0.88 (0.71–1.07) |
Note: CI = confidence interval.
For a classification of International Classification of Diseases, 9th Revision codes into cause-of-death categories, see Appendix 1 (available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.161351/-/DC1).
Proportions for causes of death do not sum to 100% because some data were suppressed, as a result of small cell sizes.
Metabolic causes of death included metabolic, nutritional, immunity and endocrine conditions, as well as diseases of the digestive system.
Accidental causes of death included motor vehicle crashes, accidental poisoning, falls, fire, and drugs or adverse events in therapeutic use.